Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study
(1) Assistant Professor, Head of the Department, Centre for Emergency Medicine Maribor, University of Maribor, Maribor, Slovenia;(2) Medical Doctor, Centre for Emergency Medicine Maribor, Maribor, Slovenia
Abstract:
Introduction
An increasing body of evidence from laboratory and clinical studies suggests that vasopressin may represent a promising alternative vasopressor for use during cardiac arrest and resuscitation. Current guidelines for cardiopulmonary resuscitation recommend the use of adrenaline (epinephrine), with vasopressin considered only as a secondary option because of limited clinical data.